Originally envisioned as a tool for any-omics age prediction and conditional multi-omics synthetic data generation and "one clock to rule them all", it evolved into a comprehensive multi-modal drug discovery platform incorporating massive amounts of data from multiple areas of biology, chemistry, drug discovery. Precious1GPT model was first presented in 2022 and
published in 2023 demonstrating the ability to discover protein targets with the case study on the role of Apelin Receptor in multiple age-related diseases.
Precious2GPT demonstrated the ability of high-quality data generation and is in peer-review process.Precious3GPT is a truly multi-modal platform and we are collaborating with Vadim Gladishev's lab at Harvard to validate and turn it into a community resource.
We plan to collaborate on Precious3GPT with multiple groups and then release it to the community.